Medexus Pharmaceuticals, Inc.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -15.75% vs 22.16% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2025 is -90.00% vs 242.86% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "35.30",
          "val2": "41.90",
          "chgp": "-15.75%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "5.70",
          "val2": "7.70",
          "chgp": "-25.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.10",
          "val2": "1.90",
          "chgp": "-42.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.80",
          "val2": "-0.90",
          "chgp": "11.11%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "0.10",
          "val2": "1.00",
          "chgp": "-90.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "66.10%",
          "val2": "126.10%",
          "chgp": "-6.00%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Mar'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2025 is -1.18% vs 6.64% in Mar 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2025 is 1,133.33% vs -118.75% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'25",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "150.70",
          "val2": "152.50",
          "chgp": "-1.18%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "25.30",
          "val2": "25.10",
          "chgp": "0.80%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "7.90",
          "val2": "14.30",
          "chgp": "-44.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-3.90",
          "val2": "-2.60",
          "chgp": "-50.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "3.10",
          "val2": "-0.30",
          "chgp": "1,133.33%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "101.80%",
          "val2": "113.10%",
          "chgp": "-1.13%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Dec'25 - YoY

Dec'25

Dec'24

Change(%)

Net Sales

35.30

41.90

-15.75%

Operating Profit (PBDIT) excl Other Income

5.70

7.70

-25.97%

Interest

1.10

1.90

-42.11%

Exceptional Items

-0.80

-0.90

11.11%

Consolidate Net Profit

0.10

1.00

-90.00%

Operating Profit Margin (Excl OI)

66.10%

126.10%

-6.00%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Dec 2025 is -15.75% vs 22.16% in Dec 2024

Consolidated Net Profit

YoY Growth in quarter ended Dec 2025 is -90.00% vs 242.86% in Dec 2024

All Quarterly Results

Annual Results Snapshot (Consolidated) - Mar'25

Mar'25

Mar'24

Change(%)

Net Sales

150.70

152.50

-1.18%

Operating Profit (PBDIT) excl Other Income

25.30

25.10

0.80%

Interest

7.90

14.30

-44.76%

Exceptional Items

-3.90

-2.60

-50.00%

Consolidate Net Profit

3.10

-0.30

1,133.33%

Operating Profit Margin (Excl OI)

101.80%

113.10%

-1.13%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Mar 2025 is -1.18% vs 6.64% in Mar 2024

Consolidated Net Profit

YoY Growth in year ended Mar 2025 is 1,133.33% vs -118.75% in Mar 2024

All Annual Results